500124:BOM
Dr Reddy's Laboratories Ltd
1 195,85 ₹
arrow_downward
-0,76%(-9,15) 1K
12-avg, 9:23:56 (GMT+5:30) · INR
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto500124 tikeri uchun statistika yaratilmoqda...
Ochish
1 200,15 ₹
Yuqori
1 206,00 ₹
Past
1 194,95 ₹
Bozor kapitali
994,01Â mlrd
Oʻrtacha hajm
0,00
Hajmi
19,30Â ming
Dividend
0,67%
Choraklik dividendlar
2,00 ₹
Eks-dividend sanasi
10-iyl, 2026
P/E koeffitsiyenti
30,92
52 haftalik eng yuqori
1 414,40 ₹
52 haftalik eng past
1 080,05 ₹
Aksiya boʻyicha daromad
38,67 ₹
Muomaladagi aksiyalar
166,06Â mln
Xodimlar soni
28Â ming
Ochish
1 200,15 ₹
Yuqori
1 206,00 ₹
Past
1 194,95 ₹
Bozor kapitali
994,01Â mlrd
Oʻrtacha hajm
0,00
Hajmi
19,30Â ming
Dividend
0,67%
Choraklik dividendlar
2,00 ₹
Eks-dividend sanasi
10-iyl, 2026
P/E koeffitsiyenti
30,92
52 haftalik eng yuqori
1 414,40 ₹
52 haftalik eng past
1 080,05 ₹
Aksiya boʻyicha daromad
38,67 ₹
Muomaladagi aksiyalar
166,06Â mln
Xodimlar soni
28Â ming
Yangiliklar
Internetdagi manbalardan
MarketBeat
·
15 soat oldin
Zacks Research Issues Pessimistic Outlook for RDY Earnings
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Dr Reddy's Laboratories Ltd haqida
CEOErez Israeli
Xodimlar soni27,5Â ming
Asos solingan1984
Bosh ofislarHaydarobod, Andhra Pradesh, Hindiston
Sektor-
Veb-saytdrreddys.com
AI kontentda xatolar boʻlishi mumkin. Batafsil